Strategic distribution is a critical link for pharmaceutical businesses due to the specialized needs of Distribution Infrastructure, Regulatory requirements, Standard Operating Procedures and stringent Audit trails, Shalimar has invested in appropriate infrastructure and incorporated all the required procedures and systems.

Shalimar has developed a “cold chain” based distribution system for high value bio-tech pharma products for a world- renowned Swiss company. Shalimar has invested in the infrastructure and put in place Standard Operating Procedures (SOP) to meet the stringent requirements of this specialised distribution. Shalimar receives the pharmaceuticals in the form of injectable vials containing live organisms through a cold chain from the manufacturer in Europe and distributes them directly to the patients in a timely manner, maintaining cold chain and keeping a complete audit trail and product control system – so essential for such biotech products having stringent shelf life and storage / inventory management requirement.

The pharmaceutical business is also exposed to the incidence of liability claims. Insurance companies too have set procedures for risk mitigation. Shalimar’s systems have been well received and have helped reduce the risk and cost of insurance.

The Division is managed by experts with long-standing experience in the business. With its insight in the direct distribution of biotech products to patients, Shalimar visualises an increasing role for itself in this growing business sector.